在早期阿尔茨海默氏症药物发现中评估计算和实验方法:系统性审查
Mahir Azmal1, Jibon Kumar Paul1, Md Naimul Haque Shohan1
1Department of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet, 3114, Bangladesh.
Journal of computer-aided molecular design
|June 6, 2025
概括
像分子对接这样的计算方法通过快速选化合物来加速阿尔茨海默病 (AD) 药物发现. 将这些in silico方法与实验验证相结合,可以更好地确定有效的治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
- 神经科学是一个神经科学.
背景情况:
- 阿尔茨海默病 (AD) 构成了全球主要的健康负担,治疗选择有限.
- 对阿尔茨海默病的传统药物发现没有产生足够的治疗突破,需要新的策略.
- 计算方法正在成为早期AD药物开发的关键工具.
研究的目的:
- 系统地审查分子对接,虚拟选和分子动力学模拟在阿尔茨海默病药物发现中的应用.
- 评估in silico方法在识别和优化针对关键AD蛋白的候选药物的有效性.
- 评估用于治疗开发的计算技术与实验验证的整合.
主要方法:
- 2000年至2024年间发表的100项研究的系统审查.
- 专注于针对乙胆酶 (AChE),β-分泌酶 (BACE1) 和陶蛋白的计算方法.
- 对整合in silico方法与体外和体内实验验证的研究进行分析.
主要成果:
- 乙胆酶 (AChE) 是最常见的向蛋白 (23项研究),其次是BACE1和多向策略.
- 使用计算方法研究了天然产品 (35项研究) 和合成化合物 (54项研究).
- 计算和实验方法的整合为药理动力学和药理动力学提供了更深入的见解.
结论:
- 计算方法显著加快了AD候选药物的识别和优化.
- 将in silico技术与实验验证相结合,可以提高对药物相互作用和机制的理解.
- 需要在计算模型和数据集成方面取得进一步的进步,以提高AD的预测准确性和治疗有效性.
更多相关视频
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
12.5K
11:57Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025
518
相关概念视频
Alzheimer's Disease: Treatment
827
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
827
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Drug Discovery: Overview
11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
